Maastricht University

Burden of disease attributable to risk factors in European countries: a scoping literature review (2023) Gorasso V, Morgado JN, Charalampous P, Pires SM, Haagsma JA, Santos JV, Idavain J, et al. Journal article, Review article 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) (2023) Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, et al. Journal article Percutaneous fractionated radiotherapy of the groin to eliminate lymphatic fistulas after vascular surgery (2023) Jazmati D, Tamaskovics B, Hoff NP, Homey B, Bölke E, Boyomo B, Garabet W, et al. Journal article Cost-effectiveness analysis of the Geriatric Fracture Center (GFC) concept: a prospective multicentre cohort study (2023) Joeris A, Sprague S, Blauth M, Gosch M, Wattanapanom P, Jarayabhand R, Poeze M, et al. Journal article Systemic Violations in EU Asylum Law: Cover or Catalyst? (2023) Tsourdi EL, Costello C Journal article Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases (2023) Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, et al. Journal article CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2023) Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, et al. Journal article Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation (2023) Ruggeri A, De Wreede LC, Muller CR, Crivello P, Bonneville EF, Petersdorf EW, Socie G, et al. Journal article FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women (2023) Figlioli G, Billaud A, Ahearn TU, Antonenkova NN, Becher H, Beckmann M, Behrens S, et al. Journal article Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial (2023) Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al. Journal article